Skip to main content
. 2021 Feb;22(2):365–370. doi: 10.31557/APJCP.2021.22.2.365

Figure 1.

Figure 1

Study Flow Diagram of Case Eligibility. NSCLC, non-small cell lung cancer; NCDB, National Cancer Database; OS, overall survival; LCNEC, large cell neuroendocrine carcinoma; IO, immunotherapy